Jorge García - Concepedia

Author

Jorge García

Also Known As

Christos Kyriakopoulos, Garcia, Jorge, J G Ibarlucea González, J Garcia, J García, J García González, J. Garcia, J. Garcia-Gonzalez, J. García, J. García Gonzalez

240

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Complejo Hospitalario Universitario de Santiago Complexo Hospitalario Universitario A Coruña Centro de Investigación Biomédica en Red de Cáncer Instituto de Investigación Sanitaria de Santiago

About

Jorge García is an author at Cleveland Clinic specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	716
2	Public Health	2	2	51
3	Biostatistics	2	2	51
4	Health Sciences	1	1	37
5	Immunology	1	1	60

Jorge García

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Hemodynamic Effects of IV Milrinone Lactate in Pediatric Patients With Septic Shock Phil Barton, Jorge García, Amjad Kouatli, CHEST Journal Iv Milrinone LactateCardiogenic ShockPediatric PatientsSepsisSeptic Shock	1996	212
Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma Anil A. Thomas, Brian I. Rini, Brian R. Lane, The Journal of Urology	2008	192
Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock Christine A. Lindsay, Phil Barton, Stephen Lawless, The Journal of Pediatrics Pediatric PatientsPediatricsMilrinone LactateSepsisSeptic Shock	1998	108
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time Jay P. Ciezki, C.A. Reddy, Jorge García, International Journal of Radiation OncologyBiologyPhysics UrologyProstate BrachytherapyPsa Bounce PhenomenonBrachytherapyProstatic Disease	2005	96
The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery Brian I. Rini, Jorge García, Paul Elson, The Journal of Urology	2012	94
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance Pedro C. Barata, Vadim S. Koshkin, Pauline Funchain, Annals of Oncology UrologyGenitourinary CancerTumor HeterogeneityMedicineNext-generation Sequencing	2017	88
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study Esther Conde, Susana Hernández, Rebeca Martínez, Journal of Thoracic Oncology	2019	69
Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience Ma Carmen Areses Manrique, Joaquín Mosquera, Jorge García, Translational Lung Cancer Research	2018	62
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab Patricia Mondelo‐Macía, Jorge García, Luis León‐Mateos, Molecular Oncology	2021	61
Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy Juan Ruiz‐Bañobre, María C. Areses-Manrique, Joaquín Mosquera, Translational Lung Cancer Research Prognostic BiomarkersCancer ImmunosurveillanceWorse LipiMedicinePrognosis	2019	60

Page 1